The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses
Open accessAbstract
Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by abundant stroma in which microenvironmental (niche) factors promote PDAC progression. In mouse models, reduction of the stroma increased the proportion of poorly differentiated PDAC with a worse prognosis. Here, we aimed to clarify the effects of stroma on PDAC that may define the PDAC phenotype and induce distinct therapeutic responses. Methods: The molecular features of PDAC based on differentiation grade were clarified by genome and transcriptome analysis using PDAC organoids (PDOs). We identified the dependency on niche factors that might regulate the differentiation grade. A three-dimensional co-culture model with cancer-associated fibroblasts (CAFs) was generated to determine whether CAFs provide niche factors essential for differentiated PDAC. PDOs were subtyped based on niche factor dependency, and the therapeutic responses for each subtype were compared. Results: The expression profiles of PDOs differed depending on the differentiation grade. Consistent with the distinct profiles, well differentiated types showed high niche dependency, while poorly differentiated types showed low niche dependency. The three-dimensional co-culture model revealed that well differentiated PDOs were strongly dependent on CAFs for growth, and moderately differentiated PDOs showed plasticity to change morphology depending on CAFs. Differentiated PDOs upregulated the expression of mevalonate pathway-related genes correlated with the niche dependency and were more sensitive to simvastatin than poorly differentiated PDOs. Conclusions: Our findings suggest that CAFs maintain the differentiated PDAC phenotype through secreting niche factors and induce distinct drug responses. These results may lead to the development of novel subtype-based therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“resulting in higher CAFs affinity for the well-differentiated PDOs compared with moderately and poorly differentiated ones”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Shinkawa et al., 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the poorly differentiated, less niche-dependent PDOs had a lower response to simvastatin and better response to gemcitabine”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Shinkawa et al., 2022
The cited source says what the claim attributes to it.
In the citing paper
“CAFs generated R-spondin 3 (RSPO3) to grade 1 PDOs and helped their growth”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Shinkawa et al., 2022
The cited source says what the claim attributes to it.
In the citing paper
“more niche-dependent organoids had the mevalonate pathway upregulated and had a better response to simvastatin”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Shinkawa et al., 2022
The cited source says what the claim attributes to it.
In the citing paper
“grade 2 PDOs demonstrated plasticity in relation to CAFs: they formed ductal structures when placed in co-culture with CAFs and solid structures without CAFs”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Shinkawa et al., 2022
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Structural absorption by barbule microstructures of super black bird of paradise feathers
McCoy, D. E., Feo, T., Harvey, T. A., & Prum, R. O. (2018) · Nature Communications · doi:10.1038/s41467-017-02088-w · Cited by 7,424
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Identification of Pancreatic Cancer Stem Cells
Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., & Simeone, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2030 · Cited by 3,339
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Cited by
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer
Cave, D. D., Buonaiuto, S., Sáinz, B., Fantuz, M., Mangini, M., Carrer, A., Domenico, A. D., Iavazzo, T. T., Andolfi, G., Cortina, C., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02516-w · Cited by 58
Shinkawa, T., Ohuchida, K., & Nakamura, M. (2022) · Cancers · doi:10.3390/cancers14163994 · Cited by 35
Self-citationDynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma
Zhang, B., Ohuchida, K., Tsutsumi, C., Shimada, Y., Mochida, Y., Oyama, K., Iwamoto, C., Sheng, N., Fei, S., Shindo, K., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03192-8 · Cited by 34
Self-citationSheng, N., Shindo, K., Ohuchida, K., Shinkawa, T., Zhang, B., Feng, H., Yamamoto, T., Moriyama, T., Ikenaga, N., Nakata, K., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1004 · Cited by 30
Self-citationZhang, W., Maeser, D., Lee, A. M., Huang, Y., Gruener, R. F., Abdelbar, I. G., Jena, S., Patel, A. G., & Huang, R. S. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3005 · Cited by 28
Metadata
- Authors
- Shinkawa, T., Ohuchida, K., Mochida, Y., Sakihama, K., Iwamoto, C., Abe, T., Ideno, N., Mizuuchi, Y., Shindo, K., Ikenaga, N., Moriyama, T., Nakata, K., Oda, Y., & Nakamura, M.
- Affiliations
- Kyushu University (JP)
- Corresponding author
- Ohuchida, Kenoki
- Nakamura, Masafumi
- ORCID
- Venue
- Journal of Experimental & Clinical Cancer Research
- Published
- 2022-03-10
- Volume
- 41
- Issue
- 1
- Pages
- 89-89
- ISSN
- 0392-9078 (ISSN-L)
- 1756-9966
- PMC
- PMC8908673
- OpenAlex
- W4220848088
- Cited by
- 41
- References
- 55
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 11 · 2022: 3
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Experimental & Clinical Cancer Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Kyushu University Institutional Repository (QIR) (Kyushu University) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (JP19H03732, JP19K22663, JP19K22664, JP21K08800)
- Fukuoka Foundation for Sound Health
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- pancreatic ductal adenocarcinoma, tumor microenvironment, cancer-associated fibroblasts, niche factors, tumor grade, mevalonate pathway, drug response, tumor stroma
- MeSH terms
- Adenocarcinoma, Animals, Disease Models, Animal, Humans, Survival Analysis, Gene Expression Profiling, Carcinoma, Pancreatic Ductal, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. https://app.cochat.ai/papers/10.1186/s13046-022-02301-9
- The paper
- Shinkawa, T., Ohuchida, K., Mochida, Y., Sakihama, K., Iwamoto, C., Abe, T., Ideno, N., Mizuuchi, Y., Shindo, K., Ikenaga, N., Moriyama, T., Nakata, K., Oda, Y., & Nakamura, M. (2022). Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-022-02301-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.